Home » Topics » Regulatory

Regulatory
RSS

FDA approves three alogliptin-based therapies for type 2 diabetes

Jan. 28, 2013

Novartis receives E.U. approval for Bexsero

Jan. 23, 2013

FDA approves first patch for treatment of migraine

Jan. 18, 2013

FDA approves Protein Sciences' Flublok seasonal influenza vaccine

Jan. 17, 2013

Biocon receives marketing authorization in India for itolizumab

Jan. 10, 2013

FDA approves Kineret for the treatment of NOMID

Jan. 10, 2013

FDA approves Fulyzaq for diarrhea in patients with HIV/AIDS

Jan. 2, 2013

FDA grants accelerated approval for Sirturo in tuberculosis

Jan. 2, 2013

FDA approves Juxtapid for homozygous familial hypercholesterolemia

Dec. 27, 2012

FDA expands approval of Tamiflu

Dec. 24, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...